|
|
|
Corporate Profile: Isis
Pharmaceuticals
| Summary: |
| Isis Pharmaceuticals exploits the
potential of antisense technology. |
| Address (HQ):
|
2855 Gazelle Court
Carlsbad, CA 92010 |
| Phone #'s (HQ): |
Main |
(760) 931-9200 |
| Human Resources |
not known |
| Investor Relations |
(760) 603-3880 |
| Fax #'s (HQ): |
Main |
(760) 603-2700 |
| Human Resources |
not known |
| Investor Relations |
(760) 931-9639 |
| email: |
Main |
info@isisph.com |
| Human Resources |
not known |
| Investor Relations |
not known |
| Financial
information: |
| ISIS |
| Issued United States patents: |
Issued U.S. patents 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
